skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Tailor-made solutions

Tailor-made-solutions

Use the expertise and experience of Pharma Intelligence to produce custom solutions that are actionable, flexible, and tailored to help you successfully navigate biopharma portfolio management, commercial optimization, and R&D strategy. Benefit from:

  • A customized approach – we develop solutions to fit your situation
  • Joint problem/opportunity definition   
  • Proprietary data and complementary market research   
  • The experience of 500+ industry experts   
  • Collaborative problem solving   
  • Fact-based decisions and actionable recommendations  
  • Ownership of final decisions and action plans

Discover new business opportunities, reduce risks, and make better, faster decisions with tailor-made pharmaceutical solutions from Pharma Intelligence.

Pharma Intelligence latest insights

  • Biomedtracker, Scrip

    39th Annual J.P. Morgan Healthcare Conference 2021

    39th Annual J.P. Morgan Healthcare Conference 2021

    Keep up with events as they unfold at the 39th Annual J.P. Morgan Annual Healthcare Conference on January 11-14, 2021. Pharma Intelligence and Insights journalists will bring you real time reporting, highlighting important events and key takeaways from every day of the largest and most informative healthcare investment symposium in the industry.

  • Pink Sheet

    UK Explains New Reliance Routes To Approval Based On EU Dossiers

    UK Explains New ‘Reliance’ Routes To Approval Based On EU Dossiers

    Companies seeking marketing authorizations in the UK or Great Britain will be able to make use of two new “reliance” procedures offering regulatory assessment times of 67 days or less if their products have already gone through the EU centralized or decentralized approval systems.

    Topic Brexit Pharma-Brexit

  • Pink Sheet

    UK BIA To Push For Post-Brexit Regulatory Agreement With EU

    UK BIA To Push For Post-Brexit Regulatory Agreement With EU

    There may not be a great deal in the new UK-EU trade and cooperation deal for the life sciences industry but a new working group could act as the forum for constructive discussions on regulatory cooperation.

    Topic Regulation Brexit Pharma-Brexit

  • Medtech Insight

    UK All-Party Report Assesses Brexit Medtech Impact While Germany Worries Over Border Delays

    UK All-Party Report Assesses Brexit Medtech Impact While Germany Worries Over Border Delays

    Government and industry in the UK are determined to make the best of the Brexit free trade deal, but German medtechs are eager for trade flow practicalities to be prioritized.

    Topic Brexit Medtech-Brexit

  • In Vivo

    The Times They Are A-Changin’: Opportunities In Medtech Regulation For The UK After Brexit

    The Times They Are A-Changin’: Opportunities In Medtech Regulation For The UK After Brexit

    The turn of the year is a chance to reflect on times past and the future, to make resolutions and look ahead to changes for the better. With Brexit in mind, this is the time to prophesize on UK medtech’s immediate future.

    Topic Regulation Market Access Medtech-Brexit

  • Pink Sheet

    Pink Sheet – US Election and New Administration Coverage

    US Elections eBook

    Stay informed of the latest news from the recent US election and understand how the shift in power will affect pharma regulatory and policy issues both within the United States and abroad. Pink Sheet takes you behind the US election headlines for analysis on the real impact you can expect to see on your business.

    Topic US Election 2020

  • In Vivo

    Pharma Intelligence Insights – Outlook 2021 Report

    In Vivo Outlook Medtech Report

    Power your strongest strategy for the year ahead with insights from the Outlook 2021 report. A combination of Scrip’s Scrip 100, Medtech Insight’s Medtech 100, and In Vivo’s Outlook reports, Outlook 2021 is a comprehensive window into the key trends, challenges and opportunities impacting the biopharma, medtech, and generics sectors for the year to come.

    Topic Outlook

  • Pink Sheet

    With US Senate Wins In Georgia, Democrats Gain Path For Rx Price Reform, But It May Be Lower Priority

    Warnock_Raphael_1200-USSenatorelect-5January2021

    Razor-thin majorities in both chambers of Congress mean Democrats can’t enact a bold agenda, and the pandemic and attendant recession mean that the initial legislative focus won’t be on Rx issues.

  • Scrip

    First In World COVID-19 Vaccine For Kids Below 12?

    First In World COVID-19 Vaccine For Kids Below 12?

    Could Serum Institute or Bharat Biotech be the first company to have a COVID-19 vaccine for children under 12 years of age? While Pfizer and Moderna have begun pediatric trials for children 12 years and above, Serum plans to begin testing its indigenous vaccine and Bharat Biotech its Covaxin in children under 12

    Topic Coronavirus

  • Pink Sheet

    UK Vaunts 'New Era' In Drug Approvals

    PS2101_Pathway_To_Future_1494901280_1200

    The UK regulator, the MHRA, has published guidance on its new integrated pathway for innovative drug approvals, which it says is intended to bring together partners including health technology assessment agencies, health care bodies and patient organizations to offer “sustained collaboration” with drug developers.

  • Scrip

    How COVID-19 Defined 2020 For Biopharma

    SP_Coronavirus_1643947495_1200

    Development of vaccines usually takes years, but drug makers whittled the process down to a matter of months amid a concerted response to a global health threat.

    Topic Coronavirus

  • Medtech Insight

    MedTech Summit 2020

    Medtech Summit Article Pack

    The annual Medtech Summit was held online in 2020, and Medtech Insight was there, reporting on the presentations from more than 100 top medical device, diagnostic, and combination product speakers and 15+ Competent Authority and Notified Body representatives. In all, over 50 hours of live and on-demand sessions with critical information and guidance were presented. 

    Topic Medtech

  • Medtech Insight

    MedTech Summit 2020

    Medtech Summit Article Pack

    The annual Medtech Summit was held online in 2020, and Medtech Insight was there, reporting on the presentations from more than 100 top medical device, diagnostic, and combination product speakers and 15+ Competent Authority and Notified Body representatives. In all, over 50 hours of live and on-demand sessions with critical information and guidance were presented. 

    Topic Medtech

  • Medtech Insight

    MedTech Summit 2020

    Medtech Summit Article Pack

    The annual Medtech Summit was held online in 2020, and Medtech Insight was there, reporting on the presentations from more than 100 top medical device, diagnostic, and combination product speakers and 15+ Competent Authority and Notified Body representatives. In all, over 50 hours of live and on-demand sessions with critical information and guidance were presented. 

    Topic Medtech

  • Medtech Insight, Meddevicetracker

    Meddevicetracker & Medtech Insight Spinal Device Markets

    Spinal Devices Article Pack

    Discover what’s on the horizon for spinal devices and technology with news, analysis, and data from Medtech Insight and Meddevicetracker. Keep up with the latest developments from the annual NASS meeting and explore extracts from two data-packed recent reports: Spinal Fusion Implanted Instrumentation and Spinal Motion Preservation Devices Market.

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: